🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this prospective, non-randomized, single-arm, phase 2 study is ...
Status
Completed
Location
Sheba MC
Start Date
2010-03
Trial ID
NCT01085565
Treatments Being Tested
The hypothesis of this feasibility study is that focal treatment with ExAbl...
Status
Completed
Location
University Health Network
Start Date
2010-10
Trial ID
NCT01226576
Treatments Being Tested
The hypothesis of this study is that focal treatment with ExAblate MRgFUS h...
Status
Completed
Location
City of Hope
Start Date
2013-10
Trial ID
NCT01657942
Treatments Being Tested
A study to evaluate the safety and initial effectiveness of the ExAblate 21...
Status
Terminated
Location
City of Hope
Start Date
2009-09
Trial ID
NCT00981578
Treatments Being Tested
The primary purpose of this protocol is to assess the ExAblate 2100 MR guid...
Status
Completed
Location
Stanford Cancer Center
Start Date
2020-11-22
Trial ID
NCT04298242
Treatments Being Tested
The purpose of this study is to evaluate the safety and ablation efficacy o...
Status
Completed
Location
University of California, Los Angeles
Start Date
2012-05
Trial ID
NCT01285960
Treatments Being Tested
This is a prospective, single-center, randomized study directly comparing o...
Status
Withdrawn
Location
Stanford University
Start Date
2024-06
Trial ID
NCT05250687
Treatments Being Tested
The primary purpose of this protocol is to assess the ExAblate 2100 MR guid...
Status
Withdrawn
Location
Stanford University
Start Date
2014-10
Trial ID
NCT02291978
Treatments Being Tested
The first magnetic resonance-guided focused ultrasound (MRgFUS) treatment o...
Status
Completed
Location
Radiopharmaceutiques hopital Bretonneau
Start Date
2010-03
Trial ID
NCT01092988
Treatments Being Tested
The objective of this trial is to evaluate the safety and efficacy of ExAbl...
Status
Withdrawn
Location
St. Mary's Hospital
Start Date
2011-06
Trial ID
NCT01328067
Treatments Being Tested